IL89491A0 - Bifunctional chimeric antibodies - Google Patents

Bifunctional chimeric antibodies

Info

Publication number
IL89491A0
IL89491A0 IL89491A IL8949189A IL89491A0 IL 89491 A0 IL89491 A0 IL 89491A0 IL 89491 A IL89491 A IL 89491A IL 8949189 A IL8949189 A IL 8949189A IL 89491 A0 IL89491 A0 IL 89491A0
Authority
IL
Israel
Prior art keywords
chimeric antibodies
bifunctional chimeric
bifunctional
antibodies
chimeric
Prior art date
Application number
IL89491A
Other languages
English (en)
Original Assignee
Hybritech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hybritech Inc filed Critical Hybritech Inc
Publication of IL89491A0 publication Critical patent/IL89491A0/xx
Priority to IL106428A priority Critical patent/IL106428A0/xx
Priority to IL106429A priority patent/IL106429A0/xx
Priority to IL106427A priority patent/IL106427A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL89491A 1988-11-17 1989-03-06 Bifunctional chimeric antibodies IL89491A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IL106428A IL106428A0 (en) 1988-11-17 1993-07-20 A host cell which secretes bifunctional chimeric cem/cha
IL106429A IL106429A0 (en) 1988-11-17 1993-07-20 Bifunctional chimeric antibodies
IL106427A IL106427A0 (en) 1988-11-17 1993-07-20 Bifunctional chimeric antibodies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27410588A 1988-11-17 1988-11-17

Publications (1)

Publication Number Publication Date
IL89491A0 true IL89491A0 (en) 1989-09-10

Family

ID=23046793

Family Applications (1)

Application Number Title Priority Date Filing Date
IL89491A IL89491A0 (en) 1988-11-17 1989-03-06 Bifunctional chimeric antibodies

Country Status (5)

Country Link
EP (1) EP0369566A3 (da)
JP (1) JPH02145187A (da)
AU (1) AU618324B2 (da)
DK (1) DK108189A (da)
IL (1) IL89491A0 (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL89489A0 (en) * 1988-03-09 1989-09-10 Hybritech Inc Chimeric antibodies directed against human carcinoembryonic antigen
IL89490A0 (en) * 1988-11-17 1989-09-10 Hybritech Inc Chimeric antibodies directed against metal chelates
IL89491A0 (en) * 1988-11-17 1989-09-10 Hybritech Inc Bifunctional chimeric antibodies
DE3920358A1 (de) * 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
WO1992010209A1 (en) * 1990-12-04 1992-06-25 The Wistar Institute Of Anatomy And Biology Bifunctional antibodies and method of preparing same
US5582996A (en) * 1990-12-04 1996-12-10 The Wistar Institute Of Anatomy & Biology Bifunctional antibodies and method of preparing same
JPH0576385A (ja) * 1990-12-18 1993-03-30 Takeda Chem Ind Ltd キメラ抗体およびその用途
ZA938243B (en) * 1992-11-12 1995-05-04 Hybritech Inc Altered affinity polypeptides of metal chelate binding antibodies
US5532136A (en) * 1993-06-22 1996-07-02 Bionebraska, Inc. Monoclonal antibody assay and kit for detecting metal cations in body fluids
GB9819411D0 (en) * 1998-09-04 1998-10-28 Ks Biomedix Ltd Antibodies
WO2005035753A1 (ja) 2003-10-10 2005-04-21 Chugai Seiyaku Kabushiki Kaisha 機能蛋白質を代替する二重特異性抗体
AU2003271186A1 (en) 2003-10-14 2005-04-27 Chugai Seiyaku Kabushiki Kaisha Double specific antibodies substituting for functional protein
AU2006232287B2 (en) 2005-03-31 2011-10-06 Chugai Seiyaku Kabushiki Kaisha Methods for producing polypeptides by regulating polypeptide association
EP2009101B1 (en) 2006-03-31 2017-10-25 Chugai Seiyaku Kabushiki Kaisha Antibody modification method for purifying bispecific antibody
CN104761637B (zh) 2006-03-31 2021-10-15 中外制药株式会社 调控抗体血液动力学的方法
ES2595638T3 (es) 2007-09-26 2017-01-02 Chugai Seiyaku Kabushiki Kaisha Método para modificar el punto isoeléctrico de un anticuerpo mediante la sustitución de aminoácidos en una CDR
TWI452136B (zh) 2010-11-17 2014-09-11 中外製藥股份有限公司 A multiple specific antigen-binding molecule that replaces the function of Factor VIII in blood coagulation
ES2881306T3 (es) 2013-09-27 2021-11-29 Chugai Pharmaceutical Co Ltd Método para la producción de heteromultímeros de polipéptidos
MA40764A (fr) 2014-09-26 2017-08-01 Chugai Pharmaceutical Co Ltd Agent thérapeutique induisant une cytotoxicité
TWI700300B (zh) 2014-09-26 2020-08-01 日商中外製藥股份有限公司 中和具有第ｖｉｉｉ凝血因子（ｆｖｉｉｉ）機能替代活性的物質之抗體
TWI701435B (zh) 2014-09-26 2020-08-11 日商中外製藥股份有限公司 測定ｆｖｉｉｉ的反應性之方法
JP7082484B2 (ja) 2015-04-01 2022-06-08 中外製薬株式会社 ポリペプチド異種多量体の製造方法
WO2017110980A1 (ja) 2015-12-25 2017-06-29 中外製薬株式会社 増強された活性を有する抗体及びその改変方法
AU2016381992B2 (en) 2015-12-28 2024-01-04 Chugai Seiyaku Kabushiki Kaisha Method for promoting efficiency of purification of Fc region-containing polypeptide
CR20180554A (es) 2016-04-28 2019-01-10 Chugai Pharmaceutical Co Ltd Preparaciones que contienen anticuerpos
US20190185578A1 (en) 2016-07-29 2019-06-20 Chugai Seiyaku Kabushiki Kaisha Bispecific antibody exhibiting increased alternative fviii-cofactor-function activity
PL3509637T3 (pl) 2016-09-06 2025-03-10 Chugai Seiyaku Kabushiki Kaisha Sposoby zastosowania dwuswoistego przeciwciała, które rozpoznaje czynnik krzepnięcia IX i/lub aktywowany czynnik krzepnięcia IX oraz czynnik krzepnięcia X i/lub aktywowany czynnik krzepnięcia X
CN110461358A (zh) 2017-03-31 2019-11-15 公立大学法人奈良县立医科大学 可用于预防和/或治疗凝血因子ⅸ异常、包含代替凝血因子ⅷ的功能的多特异性抗原结合分子的药物组合物
CN108220281A (zh) * 2017-09-25 2018-06-29 天津强微特生物科技有限公司 一种含有结合核酸的磁珠在生物样品保存液的制备和运用
PE20210005A1 (es) 2017-09-29 2021-01-05 Chugai Pharmaceutical Co Ltd Molecula de union al antigeno multiespecifica que tiene actividad de sustitucion de la funcion de cofactor del factor viii de coagulacion de sangre (fviii) y formulacion farmaceutica que contiene tal molecula como ingrediente activo
CN119161488A (zh) 2017-11-01 2024-12-20 中外制药株式会社 具有降低的生物活性的抗体变体和同种型

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1339445C (en) * 1986-11-12 1997-09-09 The General Hospital Corporation Recombinant hybrid immunoglobulin molecules and method of use
DE3853779T2 (de) * 1987-05-29 1995-09-07 Baylor College Medicine Hiv-1 neutralisierende monoklonale antikörper.
AU625613B2 (en) * 1988-01-05 1992-07-16 Novartis Ag Novel chimeric antibodies
IL89489A0 (en) * 1988-03-09 1989-09-10 Hybritech Inc Chimeric antibodies directed against human carcinoembryonic antigen
IL89491A0 (en) * 1988-11-17 1989-09-10 Hybritech Inc Bifunctional chimeric antibodies
IL89490A0 (en) * 1988-11-17 1989-09-10 Hybritech Inc Chimeric antibodies directed against metal chelates

Also Published As

Publication number Publication date
EP0369566A3 (en) 1991-10-16
EP0369566A2 (en) 1990-05-23
AU3107489A (en) 1990-05-24
JPH02145187A (ja) 1990-06-04
DK108189D0 (da) 1989-03-07
DK108189A (da) 1990-05-18
AU618324B2 (en) 1991-12-19

Similar Documents

Publication Publication Date Title
IL89491A0 (en) Bifunctional chimeric antibodies
GB8800077D0 (en) Novel chimeric antibodies
AU625613B2 (en) Novel chimeric antibodies
EP0362371A4 (en) Il-2 receptor-specific chimeric antibodies
GB8905669D0 (en) Modified antibodies
IL89489A0 (en) Chimeric antibodies directed against human carcinoembryonic antigen
AR242991A1 (es) Procedimiento para la preparacion de proteinas bifuncionales.
IL90017A0 (en) Monoclonal antibodies
IL96475A0 (en) Chimeric proteins
ZA898777B (en) Monoclonal antibodies
GB2203154B (en) Immunoglobulin conjugates
ZA89258B (en) Monoclonal antibodies
GB8726230D0 (en) Antibodies
ZA89524B (en) Antibody conjugates
IL106429A0 (en) Bifunctional chimeric antibodies
IL106427A0 (en) Bifunctional chimeric antibodies
EP0423333A4 (en) Anti-endoserine antibody
GB8820036D0 (en) Monoclonal antibodies
GB8812137D0 (en) Antibodies
GB9223676D0 (en) Modified antibodies
ZA881715B (en) Immunoglobulin conjugates
GB8812353D0 (en) Antibodies
ZA891069B (en) Antibodies
GB8818030D0 (en) Fusion constructs
GB8825331D0 (en) Mono-functional heterodimer chimeric antibodies